Galena Biopharma Retained Earnings (Accumulated Deficit) 2010-2024 | SLS

Galena Biopharma retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Galena Biopharma Retained Earnings (Accumulated Deficit) 2010-2024 | SLS

Galena Biopharma retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.